Navigation Links
Regulators Object Drug Produced from Genetically Engineered Farm Animals

European regulators have not given the green signal to a drug produced in the milk of genetically engineered farm animals// . This is a step retrograde to a budding industry that sought to enable low cost pharmaceutical options from farm animals

GTC Biotherapeutics, proponents of this drug, have decided to appeal the decision, expressing their opinion that the verdict came about only on the basis of a problem in the clinical trial, and certainly not from the fact that the drug was produced in the goats.

With a new technology there is a conservatism that is not inappropriate, Geoffrey Cox, chief executive of GTC, said during a conference call with analysts. But he added, There is no way with this company and what we have achieved over 15 years that we will let this block us from getting the product to market.

Companies like the GTC inject human genes into the animals that cause them to produce a human protein in their milk. The animal’s milk can then be used to extract the protein which can later be purified and used as a drug.

This method is cost effective and less cumbersome to produce such types of biotechnology drugs. Cancer-fighting monoclonal antibodies and many such drugs are produced using cultures of genetically engineered animal cells. These factories are a very expensive proposition costing several hundred million dollars for each factory.

Many other protein drugs, similar to the one developed by GTC, are done after the protein is extracted from donated blood. But these quantities in donated blood are found in very minimal quantities and run short to meet the actual demand. According to GTC, almost 90,000 blood donations would be required to produce the amount of protein the goats can produce in just one year.

Drug companies have been reticent to try this technology, mainly because of the wariness portrayed by drug regulators. GTC now proposes to seek the approval on its own steam to take its efforts in biotechnology forward.
'"/>




Related medicine news :

1. A brush with the U.S. Regulators can cost a fortune
2. Cancer-causing Property Of Teflon Leaves US Regulators Concerned
3. Australian Drug Regulators Call for Revamp On The Pharmaceutical Surveillance
4. Drug Regulators Need To Think In Long-Term, Say Charities
5. European Regulators Investigate Common Painkiller Drugs
6. Canadian Regulators allow Silicone Breast Implants in Market
7. New Study Challenges How Regulators Determine Risk
8. Researchers Urge Regulators to Rethink Strategies for Soot Emission
9. Local Community Objects to Mental Facility
10. Doctors Object To Elective Surgery Cuts In New South Wales
11. Healthy People 2010 Objectives Aims To Reduce Oral Health Disparities In Society
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... With over ... to walk, the demand for a sustainable product to aid in the rehabilitation process ... aid in the recovery of individuals with hemiplegia due to stroke. , Ekso Bionics ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... is bolstered by inspiring human-interest stories, courtesy of awareness-driven celebrities and thought leaders. ... from leading advocates, associations and industry leaders such as Bioness. , As ...
(Date:5/27/2016)... ... , ... Beleza Medspa has initiated a new program to assist ... first time that Coolsculpting is being used for for more than just cosmetic purposes. ... meet the prescribed body-fat standard, measured by the circumference-based tape method. The tape-test ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees in ... come courtesy of leaders in the nursing and health care industry. It also provides ... associations—namely Abilene Christian University. , As the nursing industry is coming out of ...
(Date:5/27/2016)... ... May 27, 2016 , ... With ... pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation Center is ... of successfully certified products, services and staff. , Validation Center is ISO17025 accredited ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 Amarantus BioScience ... on developing products for Regenerative Medicine, Neurology and Orphan Diseases, today ... be presenting at two upcoming investor conferences: SeeThru ... Third Avenue, New York City , NY ... Marcum MicroCap Conference   Where: Grand Hyatt ...
(Date:5/26/2016)... May 26, 2016 According to a ... Management Market - U.S. Industry Analysis, Size, Share, Growth, Trends, ... in the U.S. was valued at US$ 5.89 Bn in ... 3.4% from 2015 to 2023 to reach US$ 7.99 Bn ... current and emerging needle free drug delivery devices and the ...
(Date:5/26/2016)... -- TARE (Transarterial Radio-embolization) Using Yttrium-90 ... Overall Decreased Use of Hospital Resource ... healthcare company, has today announced the publication of ... ISPOR (International Society for Pharmacoeconomics and Outcomes Research), ... yttrium-90 glass microspheres is associated with cost savings ...
Breaking Medicine Technology: